Methodology and Applications of Disease Biomarker Identification in Human Serum

作者: Ziad J. Sahab , Suzan M. Semaan , Qing-Xiang Amy Sang

DOI: 10.4137/BMI.S0

关键词:

摘要: Biomarkers are biomolecules that serve as indicators of biological and pathological processes, or physiological pharmacological responses to a drug treatment. Because the high abundance albumin heterogeneity plasma lipoproteins glycoproteins, biomarkers difficult identify in human serum. Due clinical significance identification disease serum holds great promise for personalized medicine, especially diagnosis prognosis. This review summarizes some common emerging proteomics techniques utilized separation samples signatures. The practical application each protein technique is analyzed using specific examples. cancers prostate, breast, ovary, lung have been reviewed, well those heart disease, arthritis, asthma, cystic fibrosis. Despite advancement technology few approved by Food Drug Administration prognosis due complexity structure function lack sensitivity, specificity, reproducibility putative biomarkers. combination different types technologies statistical analysis may provide more effective methods validate new blood.

参考文章(248)
Akhilesh Pandey, Matthias Mann, None, Proteomics to study genes and genomes Nature. ,vol. 405, pp. 837- 846 ,(2000) , 10.1038/35015709
Ying Wai Lam, James A. Mobley, James E. Evans, James F. Carmody, Shuk-Mei Ho, Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer Proteomics. ,vol. 5, pp. 2927- 2938 ,(2005) , 10.1002/PMIC.200401165
Suresh Veeramani, Ta-Chun Yuan, Siu-Ju Chen, Fen-Fen Lin, Juliette E Petersen, Syed Shaheduzzaman, Shiv Srivastava, Richard G MacDonald, Ming-Fong Lin, Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer Endocrine-related Cancer. ,vol. 12, pp. 805- 822 ,(2005) , 10.1677/ERC.1.00950
Eleni Hatzinikolaou-Kotsakou, Dimitrios Tziakas, Athanasios Hotidis, Dimitrios Stakos, Dimitrios Floros, Nikolaos Papanas, Georgios Chalikias, Efstratios Maltezos, Dimitrios Ioanni Hatseras, Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. American Journal of Cardiology. ,vol. 97, pp. 659- 661 ,(2006) , 10.1016/J.AMJCARD.2005.09.104
M. R. Emmert-Buck, E. F. Petricoin, W. M. Linehan, C. Englert, D. K. Ornstein, J. W. Gillespie, C. P. Paweletz, Characterization of Intracellular Prostate-specific Antigen from Laser Capture Microdissected Benign and Malignant Prostatic Epithelium Clinical Cancer Research. ,vol. 6, pp. 353- 356 ,(2000)
Eleftherios P. Diamandis, Andreas Scorilas, Stefano Fracchioli, Marleen van Gramberen, Henk de Bruijn, Alfthan Henrik, Antoninus Soosaipillai, Linda Grass, George M. Yousef, Ulf-Hakan Stenman, Marco Massobrio, Ate GJ van der Zee, Ignace Vergote, Dionyssios Katsaros, Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma Journal of Clinical Oncology. ,vol. 21, pp. 1035- 1043 ,(2003) , 10.1200/JCO.2003.02.022
H. Towbin, T. Staehelin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 76, pp. 4350- 4354 ,(1979) , 10.1073/PNAS.76.9.4350
Eleftherios P Diamandis, Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics? Clinical Chemistry. ,vol. 49, pp. 1272- 1275 ,(2003) , 10.1373/49.8.1272
Nader Rifai, Rana Joubran, Harry Yu, Mohamad Asmi, Mohidien Jouma, None, Inflammatory Markers in Men with Angiographically Documented Coronary Heart Disease Clinical Chemistry. ,vol. 45, pp. 1967- 1973 ,(1999) , 10.1093/CLINCHEM/45.11.1967
A. Sreekumar, B. Laxman, D. R. Rhodes, S. Bhagavathula, J. Harwood, D. Giacherio, D. Ghosh, M. G. Sanda, M. A. Rubin, A. M. Chinnaiyan, Humoral Immune Response to α-Methylacyl-CoA Racemase and Prostate Cancer Journal of the National Cancer Institute. ,vol. 96, pp. 834- 843 ,(2004) , 10.1093/JNCI/DJH145